希玛医疗控股有限公司（03309）于2026年2月16日发布翌日披露报表，披露当日回购股份事宜。
公司在2026年2月16日回购了150,000股普通股，占回购前已发行股本的约0.0124%。每股购回价格为港币1.49元，合计购回金额约港币223,500元。回购后，公司已发行股份数目由1,212,200,870股减至1,212,050,870股，库藏股数量由20,142,000股增至20,292,000股，总计1,232,342,870股保持不变。
本次回购根据2025年5月19日获股东大会通过的购回授权进行，该授权允许公司回购最多125,556,087股。公司目前已使用该授权回购150,000股，占授权通过当日已发行股本的约0.0119%。公司确认此次交易符合香港联合交易所有限公司主板上市规则的相关规定。
公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.